Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fox Foundation gives $475,000 to Affiris to test its Parkinson's disease vaccine

This article was originally published in Scrip

Executive Summary

Vienna-based Affiris has received $475,000 funding from the Michael J Fox Foundation (MJFF) to complete preclinical development of its PD01 vaccine against Parkinson's disease. The company announced proof-of-concept for the vaccine last March (scripintelligence.com, 6 April 2010).

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC011364

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel